Latino GDP Surges to Fourth Largest Globally Despite Deportation Risks Over OneThird of TwoYear Mutual Fund SIPs Report Losses Market Timing and Sector Selection Matter Lessons from Betamax AIs Impact on Entertainment Business Discussed at Princeton CorpGov Forum AI Economy Reshapes Job Market BlueCollar Skilled Trades Gain as College EntryLevel Roles Slow Dating Startups Target Fake Profiles as Verification Technology Gains Traction Charter Communications Announces Improved Buyout Deal for Liberty Broadband EZRA Q1 2023 Earnings Massive EPS Surprise Driven by Unusual Items Stock Slips 49 INSM Q1 2026 Earnings EPS Beat of 2234 But Stock Declines 3 RBC Bearings Q1 2026 Earnings EPS Surpasses Expectations by Nearly 8 LAUR Q1 2026 Earnings EPS Beats Estimates Despite Negative Print Stock Slips PAYO Q1 2026 Earnings EPS Surpasses Estimates by 3245 Shares Edge Lower HUIZ Q1 2025 Earnings Massive EPS Miss Sends Shares Lower HASI Stock Edges Higher as Sustainable Infrastructure Investors Weigh Support Levels AvePoint Inc AVPT Holds Steady Near Support as Modest Gains Signal Stability National Energy Services Reunited NESR Slides 2 Amid Broader Energy Weakness Janus Henderson Group JHG Holds Steady Near Resistance as Volume Remains Modest Westin Acquisition Corp Units WSTNU Steady at 1018 Amid SPAC Market Consolidation AIA Engineering Eyes Volume Growth Through New Mining Solutions Following Earnings Beat Enhabit Inc EHAB Q4 2025 Earnings EPS Narrowly Misses Estimates Stock Edges Higher Lifezone Metals LZM Surges Over 8 as Bullish Momentum Builds OHI Q1 2026 Earnings EPS Beats Estimates Amid Market Uncertainty VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income Vodafone Q4 2025 Earnings EPS Beat of 4078 Surprises but Stock Slips on Cautious Outlook CNC Q1 2026 Earnings Robust EPS Surprise Drives Stock Higher GCI Liberty Inc Q1 2026 Earnings EPS Misses Estimates Significantly Stock Edges Higher Global Partners GLP Q1 2026 Earnings Massive EPS Beat of 455 Driven by Operational Strength CRDL Q4 2025 Earnings Narrower Than Expected Loss as Cardiol Therapeutics Advances Clinical Pipeline